» Articles » PMID: 36032110

Interleukin-18 Cytokine in Immunity, Inflammation, and Autoimmunity: Biological Role in Induction, Regulation, and Treatment

Overview
Journal Front Immunol
Date 2022 Aug 29
PMID 36032110
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-18 (IL-18) is a potent pro-inflammatory cytokine involved in host defense against infections and regulates the innate and acquired immune response. IL-18 is produced by both hematopoietic and non-hematopoietic cells, including monocytes, macrophages, keratinocytes and mesenchymal cell. IL-18 could potentially induce inflammatory and cytotoxic immune cell activities leading to autoimmunity. Its elevated levels have been reported in the blood of patients with some immune-related diseases, including rheumatoid arthritis, systemic lupus erythematosus, type I diabetes mellitus, atopic dermatitis, psoriasis, and inflammatory bowel disease. In the present review, we aimed to summarize the biological properties of IL-18 and its pathological role in different autoimmune diseases. We also reported some monoclonal antibodies and drugs targeting IL-18. Most of these monoclonal antibodies and drugs have only produced partial effectiveness or complete ineffectiveness , and human studies. The ineffectiveness of these drugs targeting IL-18 may be largely due to the loophole caused by the involvement of other cytokines and proteins in the signaling pathway of many inflammatory diseases besides the involvement of IL-18. Combination drug therapies, that focus on IL-18 inhibition, in addition to other cytokines, are highly recommended to be considered as an important area of research that needs to be explored.

Citing Articles

Advances in Mechanisms of Anaphylaxis in Wheat Allergy: Utility of Rodent Models.

Arul Arasan T, Jorgensen R, Van Antwerp C, Ng P, Gangur V Foods. 2025; 14(5).

PMID: 40077585 PMC: 11899146. DOI: 10.3390/foods14050883.


The Potential of Superoxide Dismutase-Rich as a Promoter of Cellular Health.

Cocksedge S, Mantecon L, Castano E, Infante C, Bailey S Int J Mol Sci. 2025; 26(4).

PMID: 40004157 PMC: 11855123. DOI: 10.3390/ijms26041693.


COVID-19 Induces Greater NLRP3 Inflammasome Activation in Obese Patients than Other Chronic Illnesses: A Case-Control Study.

DAmico R, Nagashima S, Carstens L, Bertoldi K, Mataruco S, Honorio DAgostini J Int J Mol Sci. 2025; 26(4).

PMID: 40004007 PMC: 11855377. DOI: 10.3390/ijms26041541.


New insights into pulmonary arterial hypertension: interaction between PANoptosis and perivascular inflammatory responses.

Su X, Sun Y, Dai A Apoptosis. 2025; .

PMID: 39979525 DOI: 10.1007/s10495-025-02086-0.


Molecular and Functional Analysis of TLR 1, 2 and 6 in Peripheral Blood Monocytes of Patients with Schizophrenia: A Pilot Study.

Sotelo-Ramirez C, Valdes-Tovar M, Zaragoza-Hoyos J, Ortiz-Lopez L, Argueta J, Rosel-Vales M Int J Mol Sci. 2025; 26(3).

PMID: 39940697 PMC: 11817014. DOI: 10.3390/ijms26030926.


References
1.
Kim J, Jang M, Jin D, Chung Y, Choi B, Park G . Paclitaxel-exposed ovarian cancer cells induce cancer‑specific CD4+ T cells after doxorubicin exposure through regulation of MyD88 expression. Int J Oncol. 2014; 44(5):1716-26. DOI: 10.3892/ijo.2014.2308. View

2.
Celik F, Coteli E, Gul F, Ozsoy E, Kobat S, Karagoz Z . Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet's disease. Int Ophthalmol. 2022; 42(11):3321-3331. DOI: 10.1007/s10792-022-02331-4. View

3.
Chandrasekar B, Patel D, Mummidi S, Kim J, Clark R, Valente A . Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving ERK1/2-dependent NFATc4 phosphorylation. J Biol Chem. 2007; 283(7):4200-9. DOI: 10.1074/jbc.M708142200. View

4.
Zhou Y, Bian P, Du H, Wang T, Li M, Hu H . The Comparison of Inflammatory Cytokines (IL-6 and IL-18) and Immune Cells in Japanese Encephalitis Patients With Different Progression. Front Cell Infect Microbiol. 2022; 12:826603. PMC: 9022626. DOI: 10.3389/fcimb.2022.826603. View

5.
Spritzer P . Inflammatory mediators in polycystic ovary syndrome: the case of interleukin-18. Arch Endocrinol Metab. 2022; 66(1):1-2. PMC: 9991032. DOI: 10.20945/2359-3997000000455. View